These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15372502)

  • 21. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.
    Amor S; O'Neill JK; Morris MM; Smith RM; Wraith DC; Groome N; Travers PJ; Baker D
    J Immunol; 1996 Apr; 156(8):3000-8. PubMed ID: 8609422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13.
    Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR
    J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.
    Raddassi K; Kent SC; Yang J; Bourcier K; Bradshaw EM; Seyfert-Margolis V; Nepom GT; Kwok WW; Hafler DA
    J Immunol; 2011 Jul; 187(2):1039-46. PubMed ID: 21653833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
    Mars LT; Bauer J; Gross DA; Bucciarelli F; Firat H; Hudrisier D; Lemonnier F; Kosmatopoulos K; Liblau RS
    J Immunol; 2007 Oct; 179(8):5090-8. PubMed ID: 17911594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A functional and structural basis for TCR cross-reactivity in multiple sclerosis.
    Lang HL; Jacobsen H; Ikemizu S; Andersson C; Harlos K; Madsen L; Hjorth P; Sondergaard L; Svejgaard A; Wucherpfennig K; Stuart DI; Bell JI; Jones EY; Fugger L
    Nat Immunol; 2002 Oct; 3(10):940-3. PubMed ID: 12244309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
    Hong J; Zang YC; Tejada-Simon MV; Kozovska M; Li S; Singh RA; Yang D; Rivera VM; Killian JK; Zhang JZ
    J Immunol; 1999 Sep; 163(6):3530-8. PubMed ID: 10477628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
    Kort JJ; Kawamura K; Fugger L; Weissert R; Forsthuber TG
    J Neuroimmunol; 2006 Apr; 173(1-2):23-34. PubMed ID: 16386804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.
    Zhong MC; Kerlero de Rosbo N; Ben-Nun A
    J Clin Invest; 2002 Jul; 110(1):81-90. PubMed ID: 12093891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis.
    Khare M; Rodriguez M; David CS
    Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.
    Khare M; Mangalam A; Rodriguez M; David CS
    J Neuroimmunol; 2005 Dec; 169(1-2):1-12. PubMed ID: 16194572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
    Markovic-Plese S; Fukaura H; Zhang J; al-Sabbagh A; Southwood S; Sette A; Kuchroo VK; Hafler DA
    J Immunol; 1995 Jul; 155(2):982-92. PubMed ID: 7541828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN; Chou YK; Whitham RH; Buckner J; Kwon HJ; Nepom GT; Buenafe A; Cooper SA; Allegretta M; Hashim GA; Offner H; Vandenbark AA
    J Immunol; 1998 Jul; 161(2):1034-44. PubMed ID: 9670985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
    Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
    Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.